{"schema_version":"secwatch.filing_event.v1","accession":"0001127537-21-000045","form_type":"8-K","ticker":"LUNG","cik":"0001127537","company_name":"Pulmonx Corp","filed_at":"2021-11-02T23:59:59+00:00","discovered_at":"2026-05-14T18:04:11.584985+00:00","generated_at":"2026-06-28T14:53:51.445178+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Pulmonx Q3 revenue $13.3M (+25% YoY); net loss $10.2M; maintains FY guidance $49-51M","bullets":["Worldwide revenue $13.3M, up 25% YoY ($10.6M Q3 2020); U.S. revenue $6.9M (+28%), international $6.4M (+22%).","Gross margin improved to 73% (70% prior year); net loss $10.2M ($0.28 loss per share) vs $3.9M ($1.37 loss per share).","Added 18 new U.S. Zephyr Valve treating centers (total 198); positive coverage decisions from Anthem, BCBS Michigan, Horizon NJ (~44M covered lives).","Cash, cash equivalents, and marketable securities totaled $202.6M as of September 30, 2021.","Maintains FY 2021 revenue guidance $49-51M; expects near low end due to COVID headwinds; operating expenses guided $83-85M."],"urls":{"canonical":"https://secwatch.observer/filing/0001127537-21-000045","json":"https://secwatch.observer/filing/0001127537-21-000045.json","markdown":"https://secwatch.observer/filing/0001127537-21-000045.md","text":"https://secwatch.observer/filing/0001127537-21-000045.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1127537/000112753721000045/0001127537-21-000045-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1127537/000112753721000045/lung-20211102.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T14:53:51.445178+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}